{"count": 2, "results": [{"_id": "11530124", "pmid": 11530124, "title": "Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth.", "journal": "Obstet Gynecol", "authors": ["Easterling TR", "Carr DB", "Brateng D", "Diederichs C", "Schmucker B"], "date": "2001-09-01T00:00:00Z", "doi": "10.1016/s0029-7844(01)01477-6", "meta_date_publication": "2001 Sep", "meta_volume": "98", "meta_issue": "3", "meta_pages": "427-33", "score": 50065.9, "text_hl": "Treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ in pregnancy: effect of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on @DISEASE_Obesity_Maternal @DISEASE_MESH:D000079262 @@@maternal disease@@@, @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm delivery@@@, and fetal growth.", "citations": {"NLM": "Easterling TR, Carr DB, Brateng D, Diederichs C, Schmucker B. Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol. 2001 Sep;98(3):427-33. PMID: 11530124", "BibTeX": "@article{11530124, title={Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth.}, author={Easterling TR and Carr DB and Brateng D and Diederichs C and Schmucker B}, journal={Obstet Gynecol}, volume={98}, number={3}, pages={427-33}}"}}, {"_id": "10371362", "pmid": 10371362, "title": "Atenolol and fetal growth in pregnancies complicated by hypertension.", "journal": "Am J Hypertens", "authors": ["Lydakis C", "Lip GY", "Beevers M", "Beevers DG"], "date": "1999-06-01T00:00:00Z", "doi": "10.1016/s0895-7061(99)00031-x", "meta_date_publication": "1999 Jun", "meta_volume": "12", "meta_issue": "6", "meta_pages": "541-7", "score": 50063.984, "text_hl": "In 91 pregnancies (29.2%) no antihypertensive drugs were given. @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ was found to be associated with lower birth weight and ponderal index values, with a trend toward a higher prevalence of @<m>DISEASE_Premature_Birth</m> @DISEASE_MESH:D047928 @@@preterm (<37 weeks) delivery@@@ and small-for-gestational-age babies when compared to other antihypertensive drugs as monotherapy, or to no treatment. ", "citations": {"NLM": "Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens. 1999 Jun;12(6):541-7. PMID: 10371362", "BibTeX": "@article{10371362, title={Atenolol and fetal growth in pregnancies complicated by hypertension.}, author={Lydakis C and Lip GY and Beevers M and Beevers DG}, journal={Am J Hypertens}, volume={12}, number={6}, pages={541-7}}"}}]}